Costing of antiepileptic drugs.
Kochen
S
S
D000085:Acetates / Q000191:economics; D000588:Amines; D000927:Anticonvulsants / Q000191:economics* / Q000627:therapeutic use; D001118:Argentina; D002220:Carbamazepine / Q000031:analogs & derivatives / Q000191:economics; D003509:Cyclohexanecarboxylic Acids; D016527:Drug Costs; D004827:Epilepsy / Q000188:drug therapy / Q000191:economics; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D000078330:Oxcarbazepine; D014227:Triazines / Q000191:economics; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000191:economics
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D014227:Triazines; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D020888:Vigabatrin; D000077213:Lamotrigine; D000078330:Oxcarbazepine